Covid-19 roundup: Stéphane Ban­cel sees De­cem­ber EUA for Mod­er­na at ear­li­est; Trump trash­es Fau­ci as 'dis­as­ter' and 'id­iot'

Stéphane Ban­cel’s new es­ti­mat­ed time­line for Mod­er­na’s Covid-19 vac­cine puts his com­pa­ny on track to score an emer­gency use au­tho­riza­tion in De­cem­ber — giv­en the in­ter­im Phase re­sults turn out pos­i­tive in No­vem­ber.

Per the tri­al pro­to­col, the first in­ter­im analy­sis of the Mod­er­na vac­cine’s ef­fi­ca­cy will hap­pen when 53 peo­ple in the en­tire study, which is en­rolling 30,000 vol­un­teers, get symp­to­matic dis­ease. The da­ta safe­ty mon­i­tor­ing board would then re­view the un­blind­ed re­sults and check the break­down be­tween the vac­ci­nat­ed and those giv­en place­bo.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER